TEVA — Recent News Coverage

All news mentioning TEVA in ESEN's AI-graded feed

News stories with TEVA as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on TEVA. See /coverage/TEVA for the 30-day aggregate.

4 articles Updated: 2026-06-19 14:20 UTC Filter: Ticker: $TEVA
MANILATIMES.NET · 2026-06-18 LOW NEUTRAL CORR0.15

Teva Releases Q2 2026 Aide Memoire

$TEVA
◈ ESEN AI
Teva Pharmaceutical released its Q2 2026 aide memoire, a preliminary financial reference document made available to investors ahead of formal earnings disclosure. This administrative announcement indicates the company i…
MANILATIMES.NET · 2026-06-18 HIGH BULLISH CORR0.72

Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome

$TEVA
◈ ESEN AI
Teva Pharmaceutical has submitted a New Drug Application to the FDA for ecopipam, marking a significant clinical milestone for a first-in-class therapy addressing pediatric Tourette syndrome. The submission is anchored …
MANILATIMES.NET · 2026-06-18 LOW NEUTRAL CORR0.00

Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET

$TEVA
◈ ESEN AI
TEVA Pharmaceutical Industries announced a routine earnings call schedule for second quarter 2026 results, set for July 29, 2026. This is a standard procedural disclosure with no material business developments or guidan…
RTTNEWS.COM · 2026-06-12 HIGH BULLISH CORR0.72

Weekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data

$LLY $TEVA $GSK $ZEAL
◈ ESEN AI
LLY, TEVA, GSK, and ZEAL are driving a significant biotech rally this week, anchored by multiple FDA and regulatory approvals across oncology, dermatology, autoimmune, and rare disease indications. The breadth of approv…
EXPLORE OTHER FILTERS